Sanopao, Baby Boy .
HRN: 21-39-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2022
AMPICILLIN 250MG (VIAL)
06/12/2022
06/18/2022
IV
155mg
Q12H
Sepsis-Clinical
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes